The benefits and drawbacks of home oxygen therapy for COPD: what's next?

Expert review of respiratory medicine Pub Date : 2024-07-01 Epub Date: 2024-07-15 DOI:10.1080/17476348.2024.2379459
Yet H Khor, Magnus Ekström
{"title":"The benefits and drawbacks of home oxygen therapy for COPD: what's next?","authors":"Yet H Khor, Magnus Ekström","doi":"10.1080/17476348.2024.2379459","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Home oxygen therapy is one of the few interventions that can improve survival in patients with chronic obstructive pulmonary disease (COPD) when administered appropriately, although it may cause side effects and be an unnecessary burden for some patients.</p><p><strong>Areas covered: </strong>This narrative review summarizes the current literature on the assessment of hypoxemia, different types of home oxygen therapy, potential beneficial and adverse effects, and emerging research on home oxygen therapy in COPD. A literature search was performed using MEDLINE and EMBASE up to January 2024, with additional articles being identified through clinical guidelines.</p><p><strong>Expert opinion: </strong>Hypoxemia is common in patients with more severe COPD. Long-term oxygen therapy is established to prolong survival in patients with chronic severe resting hypoxemia. Conversely, in the absence of chronic severe resting hypoxemia, home oxygen therapy has an unclear or conflicting evidence base, including for palliation of breathlessness, and is generally not recommended. However, beneficial effects in some patients cannot be precluded. Evidence is emerging on the optimal daily duration of oxygen use, the role of high-flow and auto-titrated oxygen therapy, improved informed decision-making, and telemonitoring. Further research is needed to validate novel oxygen delivery systems and monitoring tools and establish long-term effects of ambulatory oxygen therapy in COPD.</p>","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert review of respiratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17476348.2024.2379459","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/15 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Home oxygen therapy is one of the few interventions that can improve survival in patients with chronic obstructive pulmonary disease (COPD) when administered appropriately, although it may cause side effects and be an unnecessary burden for some patients.

Areas covered: This narrative review summarizes the current literature on the assessment of hypoxemia, different types of home oxygen therapy, potential beneficial and adverse effects, and emerging research on home oxygen therapy in COPD. A literature search was performed using MEDLINE and EMBASE up to January 2024, with additional articles being identified through clinical guidelines.

Expert opinion: Hypoxemia is common in patients with more severe COPD. Long-term oxygen therapy is established to prolong survival in patients with chronic severe resting hypoxemia. Conversely, in the absence of chronic severe resting hypoxemia, home oxygen therapy has an unclear or conflicting evidence base, including for palliation of breathlessness, and is generally not recommended. However, beneficial effects in some patients cannot be precluded. Evidence is emerging on the optimal daily duration of oxygen use, the role of high-flow and auto-titrated oxygen therapy, improved informed decision-making, and telemonitoring. Further research is needed to validate novel oxygen delivery systems and monitoring tools and establish long-term effects of ambulatory oxygen therapy in COPD.

慢性阻塞性肺病家庭氧疗的利弊:下一步该怎么办?
简介:家庭氧疗是为数不多的能够改善慢性阻塞性肺疾病(COPD)患者生存状况的干预措施之一,但如果管理得当,可能会产生副作用,并给一些患者带来不必要的负担:这篇叙述性综述总结了目前有关低氧血症评估、不同类型的家庭氧疗、潜在的有益和不利影响以及慢性阻塞性肺病家庭氧疗新兴研究的文献。我们使用 MEDLINE 和 EMBASE 对截至 2024 年 1 月的文献进行了检索,并通过临床指南确定了其他文章:低氧血症在较严重的慢性阻塞性肺疾病患者中很常见。长期氧疗可延长慢性严重静息低氧血症患者的生存期。相反,如果没有慢性严重静息低氧血症,家庭氧疗的证据基础(包括缓解呼吸困难的证据基础)不明确或相互矛盾,一般不推荐使用。不过,不能排除对某些患者产生有益影响的可能性。关于每天使用氧气的最佳时间、高流量和自动滴定氧气疗法的作用、改进知情决策和远程监控等方面的证据正在不断涌现。还需要进一步的研究来验证新型供氧系统和监测工具,并确定非卧床氧疗对慢性阻塞性肺病的长期效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信